44
Participants
Start Date
September 1, 2023
Primary Completion Date
September 15, 2024
Study Completion Date
October 1, 2024
Placebo
Patients of this group received placebo treatment consisted of two subcutaneous injections of 1 mL saline and an oral placebo
ferric carboxymaltose , α erythropoietin, vitamin B12, oral folic acid
Patients of this group received Combination treatment consisted of a slow (30 min) intravenous infusion of 20 mg/kg ferric carboxymaltose (maximum of 1000 mg), 40 000 U subcutaneous α erythropoietin,1 mg subcutaneous vitamin B12(, and 5 mg oral folic acid (acidum folicum)
tarek Abdel Lattif, Tanta
Tanta University
OTHER